A carregar...
Engineering the AAV Capsid to Evade Immune Responses
Gene therapy is progressively emerging as a promising and powerful therapeutic modality, and adeno-associated virus (AAV) is a major delivery vehicle for such therapies. Among the most significant challenges that limit AAV’s utility, however, is the immune response it elicits. Antibodies elicited by...
Na minha lista:
| Publicado no: | Curr Opin Biotechnol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7117822/ https://ncbi.nlm.nih.gov/pubmed/30807882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.copbio.2019.01.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|